argenx SE
OTC:ARGNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
argenx SE
OTC:ARGNF
|
NL |
|
1
|
1000 Yatirimlar Holding AS
IST:BINHO.E
|
TR |
|
Kestrel Gold Inc
XTSX:KGC
|
CA |
|
A
|
Agnico Eagle Mines Ltd
F:AE9
|
CA |
|
C
|
Centrotherm International AG
XMUN:CTNK
|
DE |
|
F
|
Fortis Inc
F:12F
|
CA |
|
O
|
O' will Corp
TSE:3143
|
JP |
|
P
|
Pharmadrug Inc
CNSX:PHRX
|
CA |
|
V
|
VeriSign, Inc
DUS:VRS
|
US |
|
B
|
Bank of the Philippine Islands
XPHS:BPI
|
PH |
|
Corticeira Amorim SGPS SA
F:AS4
|
PT |
|
Y
|
Yiho International Co Ltd
TPEX:7590
|
TW |
|
T
|
Tycoons Worldwide Group Thailand PCL
SET:TYCN
|
TH |
|
G
|
Garuda Metalindo Tbk PT
IDX:BOLT
|
ID |
|
E
|
Eksons Corporation Bhd
KLSE:EKSONS
|
MY |
|
Destiny Media Technologies Inc
F:DME1
|
CA |
|
Quest Holdings SA
F:9IVA
|
GR |
|
Henan Mingtai Al Industrial Co Ltd
SSE:601677
|
CN |
|
C
|
Cembre SpA
MIL:CMB
|
IT |
Bankruptcy Probability
argenx SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
argenx SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
argenx SE
XBRU:ARGX
|
49B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
503.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
190.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
98.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
35.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
argenx SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, argenx SE has total debt of 36m USD. This includes both short-term (0 USD) and long-term (36m USD) debt.
You can find a full breakdown on its Balance Sheet.